149 related articles for article (PubMed ID: 9747989)
1. Anticoagulant and antiprotease activities of a heparinoid sulfated glucoside-bearing polymer.
Onishi M; Miyashita Y; Motomura T; Yamashita S; Sakamoto N; Akashi M
J Biomater Sci Polym Ed; 1998; 9(9):973-84. PubMed ID: 9747989
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of anticoagulant activity of a novel heparinoid sulfated glucoside-bearing polymer.
Sakamoto N; Kishida A; Maruyama I; Akashi M
J Biomater Sci Polym Ed; 1997; 8(7):545-53. PubMed ID: 9195333
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticoagulant activity of sulfated glucoside-bearing polymer.
Akashi M; Sakamoto N; Suzuki K; Kishida A
Bioconjug Chem; 1996; 7(4):393-5. PubMed ID: 8853451
[TBL] [Abstract][Full Text] [Related]
4. Direct observation of fibrinogen-heparinoid complexes formation using surface plasmon resonance.
Sakamoto N; Shioya T; Serizawa T; Akashi M
Bioconjug Chem; 1999; 10(3):538-43. PubMed ID: 10346888
[TBL] [Abstract][Full Text] [Related]
5. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
[TBL] [Abstract][Full Text] [Related]
6. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides.
Wall D; Douglas S; Ferro V; Cowden W; Parish C
Thromb Res; 2001 Aug; 103(4):325-35. PubMed ID: 11562342
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulant and antiprotease activities of aprosulate sodium, a new synthetic polyanion, in human plasma and purified systems.
Sugidachi A; Asai F; Koike H
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):773-9. PubMed ID: 7865684
[TBL] [Abstract][Full Text] [Related]
9. Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane.
Han DK; Lee NY; Park KD; Kim YH; Cho HI; Min BG
Biomaterials; 1995 Apr; 16(6):467-71. PubMed ID: 7654873
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin III- and heparin cofactor II-mediated anticoagulant and antiprotease actions of heparin and its synthetic analogues.
Jeske W; Fareed J
Semin Thromb Hemost; 1993; 19 Suppl 1():241-7. PubMed ID: 8362268
[TBL] [Abstract][Full Text] [Related]
13. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
14. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
Drozd NN; Logvinova YS; Torlopov MA; Udoratina EV
Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR; Brister SJ
Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
Wun TC
Blood; 1992 Jan; 79(2):430-8. PubMed ID: 1346095
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant and antiprotease profiles of a novel natural heparinomimetic mannopentaose phosphate sulfate (PI-88).
Demir M; Iqbal O; Hoppensteadt DA; Piccolo P; Ahmad S; Schultz CL; Linhardt RJ; Fareed J
Clin Appl Thromb Hemost; 2001 Apr; 7(2):131-40. PubMed ID: 11292191
[TBL] [Abstract][Full Text] [Related]
19. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
Katz BZ; Muhl L; Zwang E; Ilan N; Herishanu Y; Deutsch V; Naparstek E; Vlodavsky I; Preissner KT
Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
[TBL] [Abstract][Full Text] [Related]
20. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
Hamano S; Nishiyama M; Kikuchi S; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
Thromb Res; 1992 May; 66(4):299-307. PubMed ID: 1329257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
